Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 254 entries
Sorted by: Best Match Show Resources per page
Signification des comportements à connotation violente et gestion des interactions dans une classe RAR

out of school settings

Vors O.
GSID: kQUTz8I0IrAJ
O Vors, N Gal-Petitfaux… - International Journal on …, 2010 - hal.archives-ouvertes.fr

Cette étude vise à comprendre comment se construisent en classe les interactions enseignant-élèves lors de leçons d'Éducation Physique dans un collège" Ambition réussite" …

Cite
Vors, O., Gal-Petitfaux, N., & Cizeron, M. (2010). Signification des comportements à connotation violente et gestion des interactions dans une classe RAR. International Journal on Violence and Schools, 11(11), 2-32.
Vors, Olivier, Nathalie Gal-Petitfaux, and Marc Cizeron. "Signification des comportements à connotation violente et gestion des interactions dans une classe RAR." International Journal on Violence and Schools 11.11 (2010): 2-32.
Copy Download .nbib Format: MLA
Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients.

Lupus science & medicine

Ramsey-Goldman R, Brar A, Richardson C, Salifu MO, Clarke A, Bernatsky S, Stefanov DG, Jindal RM.
PMID: 27335659
Lupus Sci Med. 2016 Jun 06;3(1):e000156. doi: 10.1136/lupus-2016-000156. eCollection 2016.

OBJECTIVE: We investigated malignancy risk after renal transplantation in patients with and without systemic lupus erythematosus (SLE).METHODS: Using the United States Renal Data System from 2001 to 2009, 143 652 renal transplant recipients with and without SLE contributed 585...

Cite
Ramsey-Goldman R, Brar A, Richardson C, et al. Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients. Lupus Sci Med. 2016;3(1):e000156doi: 10.1136/lupus-2016-000156.
Ramsey-Goldman, R., Brar, A., Richardson, C., Salifu, M. O., Clarke, A., Bernatsky, S., Stefanov, D. G., & Jindal, R. M. (2016). Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients. Lupus science & medicine, 3(1), e000156. https://doi.org/10.1136/lupus-2016-000156
Ramsey-Goldman, Rosalind, et al. "Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients." Lupus science & medicine vol. 3,1 (2016): e000156. doi: https://doi.org/10.1136/lupus-2016-000156
Ramsey-Goldman R, Brar A, Richardson C, Salifu MO, Clarke A, Bernatsky S, Stefanov DG, Jindal RM. Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients. Lupus Sci Med. 2016 Jun 06;3(1):e000156. doi: 10.1136/lupus-2016-000156. eCollection 2016. PMID: 27335659; PMCID: PMC4908873.
Copy Download .nbib Format: NLM
Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic.

Journal of sleep disorders & therapy

Sharma N, Lee J, Youssef I, Salifu MO, McFarlane SI.
PMID: 28638745
J Sleep Disord Ther. 2017 Mar;6(1). doi: 10.4172/2167-0277.1000260. Epub 2017 Mar 10.

Cardiovascular disease (CVD) is the main cause of death among adult men and women in the USA and impacts millions around the globe. Traditional risk factors for CVD include obesity, diabetes, hypertension and dyslipidemia. The modern-day epidemic of obesity...

Cite
Sharma N, Lee J, Youssef I, et al. Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic. J Sleep Disord Ther. 2017;6(1)doi: 10.4172/2167-0277.1000260.
Sharma, N., Lee, J., Youssef, I., Salifu, M. O., & McFarlane, S. I. (2017). Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic. Journal of sleep disorders & therapy, 6(1), . https://doi.org/10.4172/2167-0277.1000260
Sharma, Navneet, et al. "Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic." Journal of sleep disorders & therapy vol. 6,1 (2017). doi: https://doi.org/10.4172/2167-0277.1000260
Sharma N, Lee J, Youssef I, Salifu MO, McFarlane SI. Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic. J Sleep Disord Ther. 2017 Mar;6(1). doi: 10.4172/2167-0277.1000260. Epub 2017 Mar 10. PMID: 28638745; PMCID: PMC5476303.
Copy Download .nbib Format: NLM
Core-Shell Microgel-Based Surface Coatings with Linear Thermoresponse.

Langmuir : the ACS journal of surfaces and colloids

Cors M, Wrede O, Genix AC, Anselmetti D, Oberdisse J, Hellweg T.
PMID: 28628746
Langmuir. 2017 Jul 11;33(27):6804-6811. doi: 10.1021/acs.langmuir.7b01199. Epub 2017 Jun 29.

We study the swelling and shrinking behavior of core-shell microgels adsorbed on silicon wafers. In these systems, the core is made of cross-linked poly(N-isopropylmethacrylamide) and the shell consists of cross-linked poly(N-n-propylacrylamide). In suspension, these particles exhibit an extended linear...

Cite
Cors M, Wrede O, Genix AC, et al. Core-Shell Microgel-Based Surface Coatings with Linear Thermoresponse. Langmuir. 2017;33(27):6804-6811doi: 10.1021/acs.langmuir.7b01199.
Cors, M., Wrede, O., Genix, A. C., Anselmetti, D., Oberdisse, J., & Hellweg, T. (2017). Core-Shell Microgel-Based Surface Coatings with Linear Thermoresponse. Langmuir : the ACS journal of surfaces and colloids, 33(27), 6804-6811. https://doi.org/10.1021/acs.langmuir.7b01199
Cors, Marian, et al. "Core-Shell Microgel-Based Surface Coatings with Linear Thermoresponse." Langmuir : the ACS journal of surfaces and colloids vol. 33,27 (2017): 6804-6811. doi: https://doi.org/10.1021/acs.langmuir.7b01199
Cors M, Wrede O, Genix AC, Anselmetti D, Oberdisse J, Hellweg T. Core-Shell Microgel-Based Surface Coatings with Linear Thermoresponse. Langmuir. 2017 Jul 11;33(27):6804-6811. doi: 10.1021/acs.langmuir.7b01199. Epub 2017 Jun 29. PMID: 28628746.
Copy Download .nbib Format: NLM
In vivo measurement of mid-infrared light scattering from human skin.

Biomedical optics express

Michel AP, Liakat S, Bors K, Gmachl CF.
PMID: 23577287
Biomed Opt Express. 2013 Apr 01;4(4):520-30. doi: 10.1364/BOE.4.000520. Epub 2013 Mar 04.

Two mid-infrared light sources, a broadband source from a Fourier Transform Infrared Spectrometer (FTIR) and a pulsed Quantum Cascade (QC) Laser, are used to measure angle-resolved backscattering in vivo from human skin across a broad spectral range. Scattering profiles...

Cite
Michel AP, Liakat S, Bors K, et al. In vivo measurement of mid-infrared light scattering from human skin. Biomed Opt Express. 2013;4(4):520-30doi: 10.1364/BOE.4.000520.
Michel, A. P., Liakat, S., Bors, K., & Gmachl, C. F. (2013). In vivo measurement of mid-infrared light scattering from human skin. Biomedical optics express, 4(4), 520-30. https://doi.org/10.1364/BOE.4.000520
Michel, Anna P M, et al. "In vivo measurement of mid-infrared light scattering from human skin." Biomedical optics express vol. 4,4 (2013): 520-30. doi: https://doi.org/10.1364/BOE.4.000520
Michel AP, Liakat S, Bors K, Gmachl CF. In vivo measurement of mid-infrared light scattering from human skin. Biomed Opt Express. 2013 Apr 01;4(4):520-30. doi: 10.1364/BOE.4.000520. Epub 2013 Mar 04. PMID: 23577287; PMCID: PMC3617714.
Copy Download .nbib Format: NLM
Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention.

Frontiers in pediatrics

Stavsky M, Mor O, Mastrolia SA, Greenbaum S, Than NG, Erez O.
PMID: 28243583
Front Pediatr. 2017 Feb 13;5:21. doi: 10.3389/fped.2017.00021. eCollection 2017.

Cerebral palsy (CP) is the most common motor disability in childhood. This syndrome is the manifestation of intrauterine pathologies, intrapartum complications, and the postnatal sequel, especially among preterm neonates. A double hit model theory is proposed suggesting that an...

Cite
Stavsky M, Mor O, Mastrolia SA, et al. Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention. Front Pediatr. 2017;5:21doi: 10.3389/fped.2017.00021.
Stavsky, M., Mor, O., Mastrolia, S. A., Greenbaum, S., Than, N. G., & Erez, O. (2017). Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention. Frontiers in pediatrics, 521. https://doi.org/10.3389/fped.2017.00021
Stavsky, Moshe, et al. "Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention." Frontiers in pediatrics vol. 5 (2017): 21. doi: https://doi.org/10.3389/fped.2017.00021
Stavsky M, Mor O, Mastrolia SA, Greenbaum S, Than NG, Erez O. Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention. Front Pediatr. 2017 Feb 13;5:21. doi: 10.3389/fped.2017.00021. eCollection 2017. PMID: 28243583; PMCID: PMC5304407.
Copy Download .nbib Format: NLM
Optimisation of recovery protocols for double-base smokeless powder residues analysed by total vaporisation (TV) SPME/GC-MS.

Talanta

Sauzier G, Bors D, Ash J, Goodpaster JV, Lewis SW.
PMID: 27343617
Talanta. 2016 Sep 01;158:368-374. doi: 10.1016/j.talanta.2016.04.048. Epub 2016 Apr 27.

The investigation of explosive events requires appropriate evidential protocols to recover and preserve residues from the scene. In this study, a central composite design was used to determine statistically validated optimum recovery parameters for double-base smokeless powder residues on...

Cite
Sauzier G, Bors D, Ash J, et al. Optimisation of recovery protocols for double-base smokeless powder residues analysed by total vaporisation (TV) SPME/GC-MS. Talanta. 2016;158:368-374doi: 10.1016/j.talanta.2016.04.048.
Sauzier, G., Bors, D., Ash, J., Goodpaster, J. V., & Lewis, S. W. (2016). Optimisation of recovery protocols for double-base smokeless powder residues analysed by total vaporisation (TV) SPME/GC-MS. Talanta, 158368-374. https://doi.org/10.1016/j.talanta.2016.04.048
Sauzier, Georgina, et al. "Optimisation of recovery protocols for double-base smokeless powder residues analysed by total vaporisation (TV) SPME/GC-MS." Talanta vol. 158 (2016): 368-374. doi: https://doi.org/10.1016/j.talanta.2016.04.048
Sauzier G, Bors D, Ash J, Goodpaster JV, Lewis SW. Optimisation of recovery protocols for double-base smokeless powder residues analysed by total vaporisation (TV) SPME/GC-MS. Talanta. 2016 Sep 01;158:368-374. doi: 10.1016/j.talanta.2016.04.048. Epub 2016 Apr 27. PMID: 27343617.
Copy Download .nbib Format: NLM
[Genetic anticipation in idiopathic epilepsies].

Revista de neurologia

Arcos-Burgos M, Palacio LG, Sánchez JL, Jiménez ME, Mora O, Zuluaga L, Uribe CS, López-Gartner G, Jiménez I.
PMID: 10599103
Rev Neurol. 1999 Oct 1-15;29(7):597-9.

INTRODUCTION: In extended and multigenerational pedigrees, the idiopathic epilepsy phenotype shows an extreme variability.OBJECTIVE: The range of idiopathic epilepsy onset age in multigenerational pedigrees was studied in order to determine if genetic anticipation play a role in the heredity...

Cite
Arcos-Burgos M, Palacio LG, Sánchez JL, et al. Anticipación genética en epilepsia idiopática. [Genetic anticipation in idiopathic epilepsies]. Rev Neurol. 1999;29(7):597-9
Arcos-Burgos, M., Palacio, L. G., Sánchez, J. L., Jiménez, M. E., Mora, O., Zuluaga, L., Uribe, C. S., López-Gartner, G., & Jiménez, I. (1999). Anticipación genética en epilepsia idiopática. [Genetic anticipation in idiopathic epilepsies]. Revista de neurologia, 29(7), 597-9.
Arcos-Burgos, M, et al. "Anticipación genética en epilepsia idiopática." [Genetic anticipation in idiopathic epilepsies]. Revista de neurologia vol. 29,7 (1999): 597-9.
Arcos-Burgos M, Palacio LG, Sánchez JL, Jiménez ME, Mora O, Zuluaga L, Uribe CS, López-Gartner G, Jiménez I. Anticipación genética en epilepsia idiopática. [Genetic anticipation in idiopathic epilepsies]. Rev Neurol. 1999 Oct 1-15;29(7):597-9. Spanish. PMID: 10599103.
Copy Download .nbib Format: NLM
A simple sphincterometer.

The Journal of urology

BORS E.
PMID: 18874895
J Urol. 1948 Aug;60(2):287-9. doi: 10.1016/s0022-5347(17)69235-8.

No abstract available.

Cite
BORS E. A simple sphincterometer. J Urol. 1948;60(2):287-9doi: 10.1016/s0022-5347(17)69235-8.
BORS, E. (1948). A simple sphincterometer. The Journal of urology, 60(2), 287-9. https://doi.org/10.1016/s0022-5347(17)69235-8
BORS, E. "A simple sphincterometer." The Journal of urology vol. 60,2 (1948): 287-9. doi: https://doi.org/10.1016/s0022-5347(17)69235-8
BORS E. A simple sphincterometer. J Urol. 1948 Aug;60(2):287-9. doi: 10.1016/s0022-5347(17)69235-8. PMID: 18874895.
Copy Download .nbib Format: NLM
Erythropoietin stimulating agents in the management of anemia of chronic kidney disease.

Patient preference and adherence

Hayat A, Haria D, Salifu MO.
PMID: 19920963
Patient Prefer Adherence. 2008 Feb 02;2:195-200. doi: 10.2147/ppa.s2356.

Anemia is a very common clinical problem in patients with chronic kidney disease (CKD) and is associated with increased morbidity and mortality in these patients. Erythropoietin is a hormone synthesized in the kidney responsible for red blood cell maturation...

Cite
Hayat A, Haria D, Salifu MO. Erythropoietin stimulating agents in the management of anemia of chronic kidney disease. Patient Prefer Adherence. 2008;2:195-200doi: 10.2147/ppa.s2356.
Hayat, A., Haria, D., & Salifu, M. O. (2008). Erythropoietin stimulating agents in the management of anemia of chronic kidney disease. Patient preference and adherence, 2195-200. https://doi.org/10.2147/ppa.s2356
Hayat, Amir, et al. "Erythropoietin stimulating agents in the management of anemia of chronic kidney disease." Patient preference and adherence vol. 2 (2008): 195-200. doi: https://doi.org/10.2147/ppa.s2356
Hayat A, Haria D, Salifu MO. Erythropoietin stimulating agents in the management of anemia of chronic kidney disease. Patient Prefer Adherence. 2008 Feb 02;2:195-200. doi: 10.2147/ppa.s2356. PMID: 19920963; PMCID: PMC2769266.
Copy Download .nbib Format: NLM
The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

Oncology reports

Danova M, Rosti V, Mora O, Perotti C, Cazzola M, Riccardi A, Ascari E.
PMID: 21597856
Oncol Rep. 1995 Nov;2(6):1075-8. doi: 10.3892/or.2.6.1075.

This study was aimed at determining: (a) the degree of mobilization of peripheral blood hematopoietic progenitors (PBSC) induced by a single course of standard-dose chemotherapy (CT) followed by G-CSF and the feasibility and safety of the administration of multiple...

Cite
Danova M, Rosti V, Mora O, et al. The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer. Oncol Rep. 1995;2(6):1075-8doi: 10.3892/or.2.6.1075.
Danova, M., Rosti, V., Mora, O., Perotti, C., Cazzola, M., Riccardi, A., & Ascari, E. (1995). The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer. Oncology reports, 2(6), 1075-8. https://doi.org/10.3892/or.2.6.1075
Danova, M, et al. "The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer." Oncology reports vol. 2,6 (1995): 1075-8. doi: https://doi.org/10.3892/or.2.6.1075
Danova M, Rosti V, Mora O, Perotti C, Cazzola M, Riccardi A, Ascari E. The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer. Oncol Rep. 1995 Nov;2(6):1075-8. doi: 10.3892/or.2.6.1075. PMID: 21597856.
Copy Download .nbib Format: NLM
Recruitment of brown adipose tissue as a therapy for obesity-associated diseases.

Frontiers in endocrinology

Boss O, Farmer SR.
PMID: 22654854
Front Endocrinol (Lausanne). 2012 Feb 06;3:14. doi: 10.3389/fendo.2012.00014. eCollection 2012.

Brown adipose tissue (BAT) has been recognized for more than 20 years to play a key role in cold-induced non-shivering thermogenesis (CIT, NST), and body weight homeostasis in animals. BAT is a flexible tissue that can be recruited by...

Cite
Boss O, Farmer SR. Recruitment of brown adipose tissue as a therapy for obesity-associated diseases. Front Endocrinol (Lausanne). 2012;3:14doi: 10.3389/fendo.2012.00014.
Boss, O., & Farmer, S. R. (2012). Recruitment of brown adipose tissue as a therapy for obesity-associated diseases. Frontiers in endocrinology, 314. https://doi.org/10.3389/fendo.2012.00014
Boss, Olivier, and Farmer, Stephen R. "Recruitment of brown adipose tissue as a therapy for obesity-associated diseases." Frontiers in endocrinology vol. 3 (2012): 14. doi: https://doi.org/10.3389/fendo.2012.00014
Boss O, Farmer SR. Recruitment of brown adipose tissue as a therapy for obesity-associated diseases. Front Endocrinol (Lausanne). 2012 Feb 06;3:14. doi: 10.3389/fendo.2012.00014. eCollection 2012. PMID: 22654854; PMCID: PMC3356088.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 254 entries